- Health Canada DPD: SEAFORD NIFEDIPINE AND LIDOCAINE HYDROCHLORIDE CREAM (SEAFORD PHARMACEUTICALS INC, DIN 02548283) · product monograph (PDF)
Links only. These regulators' terms do not clearly permit reproducing the documents, so no text is shown here. Check the Philippine package insert in the products table.
Component information
No US or EU label exists for this exact combination, so information is shown for each component.
Use: Xylocaine (lidocaine HCl) Injections are indicated for production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous regional anesthesia by peripheral nerve block… US FDA label
Use: INDICATIONS AND USAGE Vasospastic Angina PROCARDIA XL is indicated for the management of vasospastic angina confirmed by any of the following criteria: 1) classical pattern of angina at rest accompanied by ST segment… US FDA label
Note: Fixed-dose combinations may not allow the dose changes advised for each component; check the strength and use the single agents if a component needs adjusting.
Dosing: Altered kidney function
No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.
Kidney dosing for each component (single-agent) is shown under Component information.
Kidney-specific guidance from renalcarematters.com: in preparation.
Dosage forms
Philippines
- Per g rectal cream: 3 mg/15 mg
Registered products in the Philippines
1 product registered with the Food and Drug Administration (FDA) Philippines list Lidocaine + Nifedipine as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.
| Package insert | |||||||
|---|---|---|---|---|---|---|---|
AntrolinNifedipine + Lidocaine hydrochloride | 3 mg/15 mg per g (0.3%/1.5% w/w) Rectal Cream30 g Aluminum tube with cannula and stopper (box of 1 tube) | Rx | New.Fa.Dem. S.R.L.Italy | Bliss Pharma Distribution and Consultancy Corp.Trader: Neopharmed Gentili S.p.A. | DR-XY49677 | Mar 26, 2031 |
Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.
Formulary and pricing (Philippines)
Check availability
Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.
References
- Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.
Last updated: .